Volume 24, Issue 103 (4-2016)                   J Adv Med Biomed Res 2016, 24(103): 71-80 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nasirzadeh M. Pretreatment with Olive Leaf Extract on Liver Injury Following Ischemia-Reperfusion in Male Rats. J Adv Med Biomed Res 2016; 24 (103) :71-80
URL: http://journal.zums.ac.ir/article-1-3480-en.html
Dept. of Physiology, Faculty of Veterinary Medicine, Islamic Azad University Tabriz Branch, Tabriz, Iran. , mr.nasirzadeh@iaut.ac.ir
Abstract:   (154928 Views)

Background and Objective: Wheras renal ischemic-reperfusion injury increases lipid peroxidation level in the liver tissues, it decreases the antioxidant activity and antioxidant enzymes. Olive leaves are considered as significant sources of bioactive phenolic compounds with superior antioxidant capacity, anti-inflammatory and radical scavenging.

Materials and Methods: In this study 50 male rats were allocated randomly to 5 groups: 1) control, 2) 1h I/R, 3) 1h I/R-OLE (Olive Leaf Extract), 4) 24h I/R and 5)24hI/R-OLE. The animals received 100 mg/kg olive leaf extract in 0.5 ml drinking water using gavage for 28 days in 3and 5 groups before induction of ischemia (1hour). Other animals received 0.5 ml normal saline by gavages. At the end of the reperfusion period (1and 24 hours respectively), the serum level of urea, creatinine and liver enzymes as well as antioxidant enzymes including MDA, SOD and GPX were determined in liver tissue.

Results: MDA level in OLE- treated groups decreased significantly compared to ischemic-reperfusion groups (p<0.05). In the meantime, it was detected that activity level of SOD and GPX in liver tissue of ischemic groups was significantly lower in  comparison to OLE treated groups (p<0.05).

Conclusion: This study enlightened  that OLE is a protective agent  against renal ischemic-reperfusion injury in liver tissue.

 

.

Full-Text [PDF 229 kb]   (157915 Downloads)    
Type of Study: Clinical Trials |
Received: 2016/01/11 | Accepted: 2016/01/11 | Published: 2016/01/11

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb